home / stock / evo / evo news


EVO News and Press, Evotec SE From 11/08/23

Stock Information

Company Name: Evotec SE
Stock Symbol: EVO
Market: NASDAQ
Website: evotec.com

Menu

EVO EVO Quote EVO Short EVO News EVO Articles EVO Message Board
Get EVO Alerts

News, Short Squeeze, Breakout and More Instantly...

EVO - Evotec SE reports 9M results

2023-11-08 09:08:33 ET More on Evotec SE Evotec SE (EVOTF) Q2 2023 Earnings Call Transcript Evotec SE 2023 Q2 - Results - Earnings Call Presentation Evotec SE reports 1H results; updates FY23 guidance Seeking Alpha’s Quant Rating on Evotec SE H...

EVO - Expected US Company Earnings on Wednesday, November 8th, 2023

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

EVO - Expected earnings - Evotec SE

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023

EVO - Evotec SE Reports Results for the First Nine Months 2023 and Provides Corporate Update

CONTINUATION OF STRONG GROWTH IN DEMANDING MARKETS PARADIGM-SHIFTING OFFERINGS ARE STRONGEST GROWTH DRIVERS PIPELINE PROGRESS, E.G. WITH ADVANCED ASSET IN NEURODEGENERATION ALL ELEMENTS OF GUIDANCE CONFIRMED HAMBURG, GERMANY / ACCESSWIRE / November 8, 2023 / Evotec SE (Frankf...

EVO - Evotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncology

STRATEGIC PARTNERSHIP TO ACCELERATE DEWPOINT'S LEADING ONCOLOGY PIPELINE PROGRAMMES TO INVESTIGATIONAL NEW DRUG APPLICATIONS COLLABORATION LEVERAGES EVOTEC'S FULLY INTEGRATED, CLINICAL-ENABLING INDIGO CAPABILITY PLATFORM AGREEMENT IS BASED ON A RISK-SHARING ARRANGEMENT FOLLOWED BY MILES...

EVO - Dewpoint Therapeutics Enters Strategic Partnership with Evotec to Accelerate Oncology Pipeline

PARTNERSHIP TO ACCELERATE DEWPOINT’S LEADING ONCOLOGY PIPELINE PROGRAMS TO INVESTIGATIONAL NEW DRUG APPLICATIONS COLLABORATION LEVERAGES EVOTEC’S FULLY INTEGRATED, CLINICAL-ENABLING INDIGO CAPABILITY PLATFORM AGREEMENT IS BASED ON A RISK-SHARING ARRANGEMENT FOLLOWED ...

EVO - Portfolio Update: Next Trades

2023-11-05 12:17:29 ET Summary The UST yield curve has steepened and this could provide an opportunity to buy US banking stocks on weakness in a no-recession scenario. Japan and Eurozone exporters can benefit from a global downturn due to easier central bank policies depreciating ...

EVO - Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'

A UNIQUE COMPANY CREATION VEHICLE INITIATED BY LIGHTSTONE VENTURES AND EVOTEC SE, AND ESTABLISHED WITH PARTNERS CLAVYSTBIO, LEAPS BY BAYER, POLARIS PARTNERS, AND THE POLARIS INNOVATION FUND FIRST-OF-ITS-KIND PARTNERSHIP IN SINGAPORE AND ASIA LEVERAGES BREAKTHROUGH SCIENCE FROM RESEARCHERS AT...

EVO - Evotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D Economy

LABCENTRAL, BIOLABS, MBC BIOLABS PARTNER WITH EVOTEC TO SUPPORT BIOTECH INNOVATORS THROUGH CRITICAL INFLECTION POINTS AGREEMENT LEVERAGES EVOTEC'S INTEGRATED END-TO-END SHARED R&D PLATFORM TO ENABLE GREATER ACCESS TO INDUSTRY-GRADE CAPABILITIES AND DRUG HUNTING EXPERTISE FOR LIFE SCIENCE...

EVO - Evotec and Novo Nordisk Launch LAB eN² to Accelerate Translation in Cardiometabolic Diseases

LAB eN² WILL INVOLVE INSTITUTIONS INCLUDING HARVARD UNIVERSITY, MASS GENERAL BRIGHAM, AND BETH ISRAEL DEACONESS MEDICAL CENTER FOCUS OF THE COLLABORATION IS TO ACCELERATE THE TRANSLATION OF ACADEMIC IDEAS TO THERAPEUTIC PRODUCT CANDIDATES IN THE CARDIOMETABOLIC SPACE HAMBURG, GERMA...

Previous 10 Next 10